课题基金 / 基金详情

I-Corps: Development of a bioengineered organic matrix for enhanced bone regeneration

I-Corps: Development of a bioengineered organic matrix for enhanced bone regeneration
I-Corps:开发生物工程有机基质以增强骨再生
批准号:
1462613
负责人:
Deepak Vashishth
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-11-01 至 2016-04-30

项目摘要

项目成果

Deepak Vashishth的其他基金

相似基金

相关文献

中文摘要
翻译
目前,合成骨替代物是设计很差的材料,不能有效地诱导新骨形成。使用这些产品会增加延迟骨愈合的风险。骨基质蛋白(BMP)刺激新骨形成,但价格昂贵,已知会对患者产生不良影响,FDA最近的文件显示。该团队已经开发出一种具有成本效益的有机生物材料,用于增强骨矿化和整形外科再生。通过采用上述骨蛋白质的创新材料设计方法,该项目旨在将一种新型杂化有机基质商业化,这种基质可以显著促进新骨组织的生长。骨替代物的发展寻求改变整形外科再生医学的范式。这项工作的成功将带来一种新的生物工程基质,安全地诱导新骨形成并防止骨不连的发生。骨移植手术效率的提高将直接转化为降低医院成本和改善患者结果。非胶原蛋白(NCPs)、骨钙素(OC)和骨桥蛋白(OPN)是骨的构建块,在矿化过程中由细胞释放到细胞外环境中,由于它们与骨矿物质的亲和力而被结合到基质中。OC和OPN被认为是骨基质质量的强大调节者,强烈影响骨的机械完整性。NCPs是连接骨胶原和骨基质矿物相的连接蛋白,也是骨矿物质特性的调节因子。由于与骨基质中的矿物相和胶原相相互作用,NCPs具有自我修复的潜力,使其成为骨科再生领域的理想候选材料。通过为身体提供这些骨骼构建块,该团队寻求实现增强矿化和加速骨骼再生。该团队正在制造和表征含有NCP的胶原基基质,现在需要通过体外和体内研究来表征和测试有效性。与临床医生和天使投资者的初步对话使该团队相信,成功的疗效测试将是其创新商业化的一个重要里程碑。
英文摘要
Currently, synthetic bone substitutes are poorly designed materials that do not effectively induce new bone formation. Use of these products increases risk of delayed bone healing. Bone matrix proteins (BMPs) stimulate new bone formation, but are expensive and are known to cause adverse effects in patients, as documented recently by the FDA. The team has developed a cost-effective, organic biomaterial for enhanced bone mineralization and orthopedic regeneration. Through the use of an innovative, materials design approach employing the aforementioned bone proteins, this project aims at commercializing a new class of hybrid organic matrices that can significantly enhance the growth of new bone tissue. The development of the bone substitute seeks to shift paradigms in orthopedic regenerative medicine. The success of this work will usher in a new class of bioengineered matrices that safely induce new bone formation and prevent occurrence of non-unions. An increased efficacy in bone grafting procedures will directly translate to lowered hospitals costs and better patient outcomes.Non-collagenous proteins (NCPs) osteocalcin (OC) and osteopontin (OPN) are building blocks of bone, and are released by cells into the extracellular environment during the mineralization process, where they are incorporated into the matrix due to their affinity for bone mineral. OC and OPN are considered powerful regulators of bone matrix quality, strongly influencing mechanical integrity of bone. NCPs function as link proteins connecting the collagen and mineral phases of bone matrix together, and as regulators of bone mineral properties. The self-healing potential of NCPs due, to their interactions with both, the mineral and collagen phases in bone matrix, makes them ideal candidates to explore in the field of orthopedic regeneration. By providing the body with these building blocks of bone, the team seeks to achieve enhanced mineralization and accelerated bone regeneration. The team is fabricating and characterizing collagen-based matrices containing NCPs that now need to be characterized and tested for efficacy through in vitro and in vivo studies. Preliminary conversations with clinicians and angel investors, have led the team to believe that a successful test of efficacy will be a significant milestone in the commercialization of its innovation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A New Self-healing Mechanism and its Impact on Multiscale Biomechanics of Bone
  • 批准号:
    1363526
  • 项目类别:
    Standard Grant
  • 资助金额:
    $39.0万
  • 财政年份:
    2014
  • 负责人:
    Deepak Vashishth
  • 依托单位:
国内基金
海外基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    40万元
  • 批准年份:
    2020
  • 负责人:
    Vikrant Gupta
  • 依托单位: